{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:59:05Z","timestamp":1791658745445,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1212040016"],"award-info":[{"award-number":["2021B1212040016"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270697"],"award-info":[{"award-number":["82270697"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012574"],"award-info":[{"award-number":["2023A1515012574"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.exphem.2025.104752","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:13:33Z","timestamp":1741781613000},"page":"104752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells"],"prefix":"10.1016","volume":"145","author":[{"given":"Min","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Kai","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-3190","authenticated-orcid":false,"given":"Yun-Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.exphem.2025.104752_bib0001","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0140-6736(15)60823-6","article-title":"The global blood supply: a literature review","volume":"385","author":"Kralievits","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2025.104752_bib0002","first-page":"353","article-title":"Blood transfusion during World War I (1914 - 1918)","volume":"50","author":"Aymard","year":"2016","journal-title":"Hist Sci Med"},{"key":"10.1016\/j.exphem.2025.104752_bib0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-med-070119-115617","article-title":"Hematopoietic stem cell transplantation for autoimmune disease","volume":"72","author":"Alexander","year":"2021","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.exphem.2025.104752_bib0004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","article-title":"Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Saad","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.exphem.2025.104752_bib0005","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","article-title":"Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions","volume":"9","author":"Chang","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.exphem.2025.104752_bib0006","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-023-05739-9","article-title":"Chemically defined cytokine-free expansion of human haematopoietic stem cells","volume":"615","author":"Sakurai","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104752_bib0007","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1125","article-title":"Umbilical-cord blood transplantation for the treatment of cancer","volume":"3","author":"Barker","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2025.104752_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1359-6101(00)00004-6","article-title":"Can cord blood cells support the cytokine storm in GvHD?","volume":"11","author":"Cohen","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.exphem.2025.104752_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.exphem.2023.08.006","article-title":"Engineered hematopoietic and immune cells derived from human pluripotent stem cells","volume":"127","author":"Chang","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2025.104752_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2025.104752_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"7","author":"Tang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.exphem.2025.104752_bib0012","first-page":"1439","article-title":"Clinical practice guideline: red blood cell transfusion in adult trauma and critical care","volume":"67","author":"Napolitano","year":"2009","journal-title":"J Trauma"},{"key":"10.1016\/j.exphem.2025.104752_bib0013","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/emermed-2019-209040","article-title":"Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage","volume":"37","author":"Avery","year":"2020","journal-title":"Emerg Med J"},{"key":"10.1016\/j.exphem.2025.104752_bib0014","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.104752_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tmrv.2020.09.009","article-title":"New emerging developments of platelets in transfusion medicine","volume":"34","author":"Stolla","year":"2020","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.exphem.2025.104752_bib0016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bja\/aes139","article-title":"Patient blood management in Europe","volume":"109","author":"Shander","year":"2012","journal-title":"Br J Anaesth"},{"issue":"Suppl 2","key":"10.1016\/j.exphem.2025.104752_bib0017","first-page":"1S","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2025.104752_bib0018","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tracli.2017.06.014","article-title":"Occult hepatitis B infection and transfusion-transmission risk","volume":"24","author":"Candotti","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.exphem.2025.104752_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tmrv.2017.05.002","article-title":"Emerging infectious diseases and blood safety: modeling the transfusion-transmission risk","volume":"31","author":"Kiely","year":"2017","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.exphem.2025.104752_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/voxs.12070","article-title":"Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections","volume":"9","author":"Stramer","year":"2014","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.exphem.2025.104752_bib0021","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: induction and consequences","volume":"133","author":"Tormey","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0022","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1186\/cc2847","article-title":"Infectious and immunologic consequences of blood transfusion","volume":"8","author":"Dellinger","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.exphem.2025.104752_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100926","article-title":"Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions","volume":"53","author":"Tung","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2025.104752_bib0024","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature22370","article-title":"Haematopoietic stem and progenitor cells from human pluripotent stem cells","volume":"545","author":"Sugimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104752_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphys.2014.00003","article-title":"Primitive and definitive erythropoiesis in mammals","volume":"5","author":"Palis","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.exphem.2025.104752_bib0027","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13287-020-01998-9","article-title":"Differentiation of human induced pluripotent stem cells into erythroid cells","volume":"11","author":"Ebrahimi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exphem.2025.104752_bib0028","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.exphem.2006.07.003","article-title":"Large-scale production of embryonic red blood cells from human embryonic stem cells","volume":"34","author":"Olivier","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2025.104752_bib0029","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1089\/scd.2011.0078","article-title":"Generation of red blood cells from human induced pluripotent stem cells","volume":"20","author":"Dias","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.exphem.2025.104752_bib0030","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/bloodadvances.2017006866","article-title":"Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma","volume":"1","author":"Casneuf","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2025.104752_bib0031","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1182\/blood-2015-12-629055","article-title":"Exploitation of natural killer cells for the treatment of acute leukemia","volume":"127","author":"Handgretinger","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2025.104752_bib0033","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood.2019000621","article-title":"Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity","volume":"135","author":"Zhu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0034","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.4049\/jimmunol.166.4.2163","article-title":"Cutting edge commentary: origins of B-1 cells","volume":"166","author":"Wortis","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.104752_bib0035","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood-2010-08-299941","article-title":"Human induced pluripotent stem cells are capable of B-cell lymphopoiesis","volume":"117","author":"Carpenter","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0036","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood-2004-04-1649","article-title":"Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential","volume":"105","author":"Vodyanik","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0037","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/hum.2020.159","article-title":"HIV gene therapy: an update","volume":"32","author":"Cornu","year":"2021","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.exphem.2025.104752_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1352805","article-title":"Adoptive T cell therapy for solid tumors: current landscape and future challenges","volume":"15","author":"Albarr\u00e1n","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2025.104752_bib0039","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.4049\/jimmunol.0803670","article-title":"Generation of T cells from human embryonic stem cell-derived hematopoietic zones","volume":"182","author":"Timmermans","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.104752_bib0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-020-20658-3","article-title":"A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy","volume":"12","author":"Iriguchi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.104752_bib0041","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.2023020528","article-title":"Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8\u03b1\u03b2+ T cells targeting multiple myeloma","volume":"143","author":"Bae","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0042","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.exphem.2025.104752_bib0043","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/334395a0","article-title":"T-cell antigen receptor genes and T-cell recognition","volume":"334","author":"Davis","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104752_bib0044","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104752_bib0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The principles of engineering immune cells to treat cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0046","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.stem.2022.02.009","article-title":"3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0047","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","article-title":"Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine","volume":"95","author":"Lapillonne","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104752_bib0048","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stemcr.2014.01.014","article-title":"Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells","volume":"2","author":"Valamehr","year":"2014","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.exphem.2025.104752_bib0049","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.exphem.2013.04.007","article-title":"Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes","volume":"41","author":"Nakagawa","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2025.104752_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104752_bib0051","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1084\/jem.20111688","article-title":"Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region","volume":"208","author":"Ivanovs","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.104752_bib0052","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1242\/dev.125.22.4575","article-title":"Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny","volume":"125","author":"Jaffredo","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.exphem.2025.104752_bib0053","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1634\/stemcells.2008-0922","article-title":"Hematopoietic and endothelial differentiation of human induced pluripotent stem cells","volume":"27","author":"Choi","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2025.104752_bib0054","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/cc.23823","article-title":"Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells","volume":"12","author":"Slukvin","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2025.104752_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1242\/dev.111.2.259","article-title":"Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture","volume":"111","author":"Wiles","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.exphem.2025.104752_bib0056","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13619-023-00175-6","article-title":"Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges","volume":"12","author":"Zheng","year":"2023","journal-title":"Cell Regen"},{"key":"10.1016\/j.exphem.2025.104752_bib0057","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4252\/wjsc.v12.i1.25","article-title":"Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach","volume":"12","author":"Guo","year":"2020","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.exphem.2025.104752_bib0058","article-title":"Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells","author":"Ng","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2025.104752_bib0059","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.stem.2023.11.002","article-title":"Generation of transgene-free hematopoietic stem cells from human induced pluripotent stem cells","volume":"30","author":"Piau","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0060","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.devcel.2024.03.003","article-title":"Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells","volume":"59","author":"Fowler","year":"2024","journal-title":"Dev Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0061","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1213\/ANE.0000000000004844","article-title":"Essential role of patient blood management in a pandemic: a call for action","volume":"131","author":"Shander","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.exphem.2025.104752_bib0062","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0063","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/10915818221150790","article-title":"Non-clinical cell therapy development using the NCG mouse model as a test system","volume":"42","author":"Smutova","year":"2023","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.exphem.2025.104752_bib0064","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104752_bib0065","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nm.3647","article-title":"Hematopoietic stem cell niche maintenance during homeostasis and regeneration","volume":"20","author":"Mendelson","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2025.104752_bib0066","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13287-021-02189-w","article-title":"Fetal liver hematopoiesis: from development to delivery","volume":"12","author":"Lewis","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exphem.2025.104752_bib0067","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11427-018-9313-4","article-title":"Fetal liver: an ideal niche for hematopoietic stem cell expansion","volume":"61","author":"Gao","year":"2018","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.exphem.2025.104752_bib0068","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/dev.040998","article-title":"Embryonic origin of the adult hematopoietic system: advances and questions","volume":"138","author":"Medvinsky","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.exphem.2025.104752_bib0069","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165723","article-title":"Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity","volume":"133","author":"Li","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.104752_bib0070","unstructured":"Geneva, General Requirements for Human and Mouse Pluripotent Stem Cells. International Organization for Standardization. 2022. ISO 24603. https:\/\/www.iso.org\/standard\/79046.html"},{"key":"10.1016\/j.exphem.2025.104752_bib0071","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41592-024-02172-2","article-title":"Generation of complex bone marrow organoids from human induced pluripotent stem cells","volume":"21","author":"Frenz-Wiessner","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2025.104752_bib0072","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/08977194.2015.1088534","article-title":"Kinetics of hematopoietic stem cells and supportive activities of stromal cells in a three-dimensional bone marrow culture system","volume":"33","author":"Harada","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.exphem.2025.104752_bib0073","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.cell.2024.03.032","article-title":"Hematopoietic stem cell niche generation and maintenance are distinguishable by an epitranscriptomic program","volume":"187","author":"Gao","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0074","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41586-022-04571-x","article-title":"Mapping human haematopoietic stem cells from haemogenic endothelium to birth","volume":"604","author":"Calvanese","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104752_bib0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.stem.2018.04.014","article-title":"Single-Cell transcriptomics meets lineage tracing","volume":"23","author":"Kester","year":"2018","journal-title":"cell stem cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0076","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104752_bib0077","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/stem.1036","article-title":"Mechanism of action of HOXB4 on the hematopoietic differentiation of embryonic stem cells","volume":"30","author":"Forrester","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2025.104752_bib0078","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2004-04-1653","article-title":"Molecular interactions involved in HOXB4-induced activation of HSC self-renewal","volume":"104","author":"Beslu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104752_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1250827","article-title":"The role of GATA2 in adult hematopoiesis and cell fate determination","volume":"11","author":"Peters","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.exphem.2025.104752_bib0080","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/dvdy.230","article-title":"Notch signaling and the emergence of hematopoietic stem cells","volume":"249","author":"Lomel\u00ed","year":"2020","journal-title":"Dev Dyn"},{"key":"10.1016\/j.exphem.2025.104752_bib0081","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41467-022-28775-x","article-title":"A specialized bone marrow microenvironment for fetal haematopoiesis","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.104752_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122812","article-title":"Human amniotic mesenchymal stem cell-islet organoids enhance the efficiency of islet engraftment in a mouse diabetes model","volume":"351","author":"Zhou","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.exphem.2025.104752_bib0083","doi-asserted-by":"crossref","first-page":"aaf7907","DOI":"10.1126\/science.aaf7907","article-title":"Whole-organism lineage tracing by combinatorial and cumulative genome editing","volume":"353","author":"McKenna","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104752_bib0084","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.devcel.2020.10.021","article-title":"Next-generation lineage tracing and fate mapping to interrogate development","volume":"56","author":"VanHorn","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.exphem.2025.104752_bib0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41556-019-0308-3","article-title":"Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells","volume":"21","author":"Nakahara","year":"2019","journal-title":"Nat Cell Biol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:46:27Z","timestamp":1762285587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":85,"alternative-id":["S0301472X25000438"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104752","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104752"}}